Focus on Leukemia
Five types of standard treatment are used for CLL.
Chronic lymphocytic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell). CLL, a slow-growing blood and bone marrow disease, is one of the most common types of leukemia in adults.
Treatment options and recommendations for people with chronic myeloid leukemia depend on several factors, including the phase of the disease, possible side effects, and your preferences and overall health. Take time to learn about your treatment options, and be sure to ask questions about things that are unclear. Also, discuss the goals of each treatment with your doctor and ask what you can expect while receiving the treatment.
The U.S. Food and Drug Administration has approved Gazyva (obinutuzumab) for use in combination with chlorambucil to treat patients with previously untreated chronic lymphocytic leukemia (CLL). Gazyva works by helping certain cells in the immune system attack cancer cells. Gazyva is intended to be used with chlorambucil, another drug used to treat patients with CLL.